Imaging tumor perfusion and oxidative metabolism in patients with head-and-neck cancer using 1- [11C]-acetate PET during radiotherapy: preliminary results.

BACKGROUND A growing body of in vitro evidence links alterations of the intermediary metabolism in cancer to treatment outcome. This study aimed to characterize tumor oxidative metabolism and perfusion in vivo using dynamic positron emission tomography (PET) with 1- [(11)C]-acetate (ACE) during radiotherapy. METHODS AND MATERIALS Nine patients with head-and-neck cancer were studied. Oxidative metabolic rate (k(mono)) and perfusion (rF) of the primary tumors were assessed by dynamic ACE-PET at baseline and after 15, 30, and 55 Gy was delivered. Tumor glucose uptake (Tglu) was evaluated with [(18)F]-fluorodeoxyglucose PET at baseline. Patients were grouped into complete (CR, n = 6) and partial responders (PR, n = 3) to radiotherapy. RESULTS The 3 PR patients died within a median follow-up period of 33 months. Baseline k(mono) was almost twice as high in CR as in PR (p = 0.02) and Tglu was lower in CR than in PR (p = 0.04). k(mono) increased during radiotherapy in PR (p = 0.004) but remained unchanged in CR. There were no differences in rF between CR and PR at any dosage. k(mono) and rF were coupled in CR (p = 0.001), but not in PR. CONCLUSIONS This study shows that radiosensitive tumors might rely predominantly on oxidative metabolism for their bioenergetic needs. The impairment of oxidative metabolism in radioresistant tumors is potentially reversible, suggesting that therapies targeting the intermediary metabolism might improve treatment outcome.

[1]  S. Bergmann,et al.  Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  C. Visser,et al.  Carbon-11 acetate as a tracer of myocardial oxygen consumption , 2001, European Journal of Nuclear Medicine.

[3]  D. Chinkes,et al.  Regional acetate kinetics and oxidation in human volunteers. , 1998, The American journal of physiology.

[4]  Yubo Sun,et al.  Oxidative phosphorylation dysfunction modulates expression of extracellular matrix--remodeling genes and invasion. , 2006, Carcinogenesis.

[5]  J. Bussink,et al.  TUMOR MICROENVIRONMENT IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS : PREDICTIVE VALUE AND CLINICAL RELEVANCE OF HYPOXIC MARKERS , 2007 .

[6]  F. López-Ríos,et al.  Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. , 2007, Cancer research.

[7]  A. Alavi,et al.  Staging with PET and the “Will Rogers” effect: redefining prognosis and survival in patients with cancer , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  Emma Saavedra,et al.  Energy metabolism in tumor cells , 2007, The FEBS journal.

[9]  J. Ehrhardt,et al.  Assessment of Blood Flow in Solid Tumors Using PET. , 1998, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[10]  P. Therasse,et al.  Evaluation of response: new and standard criteria. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  Thomas Scholbach,et al.  pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia? , 2007, BMC Cancer.

[12]  M. Phelps,et al.  Use of the metabolic tracer carbon-11-acetate for evaluation of regional myocardial perfusion. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  W. Weber.  Positron emission tomography as an imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  E. Nissinen,et al.  The energy charge in wild‐type and respiration‐deficient chinese hamster cell mutants , 1980, Journal of cellular physiology.

[15]  N. Denko,et al.  HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. , 2006, Cell metabolism.

[16]  Chi-Lai Ho,et al.  11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  Jacques Bernier,et al.  Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. , 2004, The New England journal of medicine.

[18]  B. Långström,et al.  1-[11C]-acetate PET imaging in head and neck cancer—a comparison with 18F-FDG-PET: implications for staging and radiotherapy planning , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[19]  H R Schelbert,et al.  Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. , 1990, Circulation.

[20]  P. Malmström,et al.  Positron emission tomography with C11-acetate for tumor detection and localization in patients with prostate-specific antigen relapse after radical prostatectomy. , 2006, Urology.

[21]  M E Phelps,et al.  Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography. , 1989, Circulation.

[22]  M. Janier,et al.  Validation of Renal Oxidative Metabolism Measurement by Positron-Emission Tomography , 2007, Hypertension.

[23]  M. Ristow.  Oxidative metabolism in cancer growth , 2006, Current opinion in clinical nutrition and metabolic care.

[24]  David L Buckley,et al.  Imaging vascular physiology to monitor cancer treatment. , 2006, Critical reviews in oncology/hematology.

[25]  Jens Sörensen,et al.  [18F]Fluoroacetate is not a functional analogue of [11C]acetate in normal physiology , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[26]  O. Warburg.  On respiratory impairment in cancer cells. , 1956, Science.

[27]  M. Eble,et al.  Oxygenation of Advanced Head and Neck Cancer: Prognostic Marker for the Response to Primary Radiochemotherapy , 2000, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[28]  J. Nelson,et al.  Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model , 2003, The Prostate.

[29]  A. Maitra,et al.  Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck , 2007, Proceedings of the National Academy of Sciences.

[30]  I. Nishimoto,et al.  Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study. , 2004, Oral oncology.